GT Biopharma

About:

GT Biopharma specializes in the research and development of therapeutic products used primarily for the treatment of cancer.

Website: https://www.gtbiopharma.com/

Twitter/X: oxisintl

Top Investors: Armando Soto

Description:

GT Biopharma, Inc. is a clinical stage biopharmaceutical company focused on the development and commercialization of immunology therapeutic products based on our proprietary Trispecific Killer Engagers (TriKE™) target-directed Natural Killer (NK) cell engager platform. The TriKE™ NK protein biologic platform is designed to harness and amplify the body’s native immune system for hope for patients with cancer and infectious diseases.